Literature DB >> 15708553

Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus.

Irene Lagogianni1, Aggeliki Papapanagiotou, Christina Piperi, Christos Kalofoutis, George Troupis, Ariadni Zachari, Anastasios Kalofoutis.   

Abstract

OBJECTIVES: The aim of the present study was to evaluate the dyslipidemic profile of patients with Cutaneous Discoid Lupus Erythematosus (DLE) with particular emphasis on the levels of High Density Lipoprotein (HDL) Cholesterol and its subfractions, HDL2 and HDL3. DESIGN AND
METHOD: The study involved characterization of the lipid profile of 30 patients with diagnosed DLE (11 male and 19 female) and 34 age- and BMI-matched healthy individuals.
RESULTS: Patients with DLE presented increased serum cholesterol, triglycerides and LDL-Cholesterol levels (P < 0.001, respectively) compared to the control group, while the levels of HDL-Cholesterol (P < 0.001), as well as its subfractions, HDL2 (P < 0.001) and HDL3 (P < 0.02) were markedly decreased. In addition, the ratio of CHOL/HDL was increased in patients with DLE (P < 0.001), whereas a reduction was observed in the ratio of HDL2/HDL3 (P < 0.001) in the same group.
CONCLUSIONS: Our findings suggest that patients with cutaneous discoid lupus erythematosus have an increased risk of atherosclerosis due to the marked dyslipidemia associated with the disease. The reduced levels of HDL subfractions, HDL2 and HDL3, are believed to contribute to the dyslipidemic profile and further provide an important target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708553     DOI: 10.1016/j.clinbiochem.2004.10.006

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

Review 1.  Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis.

Authors:  Lisa N Guo; Vinod E Nambudiri
Journal:  Clin Rheumatol       Date:  2020-07-05       Impact factor: 2.980

2.  Modeling the time evolution of the nanoparticle-protein corona in a body fluid.

Authors:  Daniele Dell'Orco; Martin Lundqvist; Cecilia Oslakovic; Tommy Cedervall; Sara Linse
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

3.  Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus.

Authors:  Cecilia P Chung; Annette Oeser; Paolo Raggi; Joseph F Solus; Ingrid Avalos; MacRae F Linton; Sergio Fazio; C Michael Stein
Journal:  Clin Rheumatol       Date:  2008-04-18       Impact factor: 2.980

Review 4.  Dyslipidemia in Dermatological Disorders.

Authors:  Chetana Shenoy; Manjunath Mala Shenoy; Gururaja K Rao
Journal:  N Am J Med Sci       Date:  2015-10

Review 5.  Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis.

Authors:  Emily Keyes; Madison Grinnell; Douglas Jacoby; Thomas Vazquez; DeAnna Diaz; Victoria P Werth; Kevin Jon Williams
Journal:  Int J Womens Dermatol       Date:  2021-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.